News Center
  • Feb 12, 2026
    Arctic Vision Announces Deal to Integrate MDCO Technology's Ophthalmic Device Business to Form a Global Drug–Device Innovation Platform

    Arctic Vision Announces Deal to Integrate MDCO Technology

  • Feb 18, 2026
    Arctic Vision Announced CDE Acceptance of New Drug Application for ARCATUS® (ARVN001) to Treat Uveitic Macular Edema (UME) in China

    Arctic Vision Announces Deal to Integrate MDCO Technology

  • Jan 02, 2026
    Arctic Vision Announced TGA Approval of New Drug Application for ARCATUS® (ARVN001) to Treat Uveitic Macular Edema (UME) in Australia

    ARVNO01 to Treat Uveitic Macular Edema (UME) in Australia

  • Jan 02, 2026
    Arctic Vision Wins the Hurun Future Unicorns Global Gazelles Index of 2024

    Arctic Vision Wins the Hurun Future Unicorns Global Gazelles Index of 2024

  • Jan 05, 2026
    Santen Pharmaceutical and Arctic Vision execute a commercial collaboration agreement for ARVN001, a suprachoroidal space injection therapy for the treatment of uveitic macular edema

    Santen Pharmaceutical and Arctic Vision execute a commercialcollaboration agreement for...

  • Jan 20, 2026
    Innovation is everywhere – Hong Kong Enterprise Innovation Project Selection and Recognition Conference came to a Successful Conclusion

    Innovation is everywhere